Brazil's health regulator has suspended Covaxin's emergency-use application, which was filed by an intermediary on behalf of the COVID-19 vaccine's developer Bharat Biotech, as reported in This is Money.

Anvisa said the intermediary, Precisa, did not submit, or only partially submitted, mandatory and essential documents for the vaccine.
Covaxin has become highly controversial in Brazil over allegations of "irregularities" in the government's efforts to buy 20 million doses.










(All Rights Reserved)